Hakala S, Hamalainen A, Sandelin S, Giannareas N, Narva E
Cells. 2025; 14(2).
PMID: 39851576
PMC: 11764358.
DOI: 10.3390/cells14020148.
Moritz J, Schwab A, Reinisch A, Zebisch A, Sill H, Wolfler A
Biomedicines. 2024; 12(3).
PMID: 38540210
PMC: 10968436.
DOI: 10.3390/biomedicines12030599.
Raimo M, Zavoianu A, Meijs W, Scholten P, Spanholtz J
Heliyon. 2024; 10(2):e24715.
PMID: 38304826
PMC: 10830575.
DOI: 10.1016/j.heliyon.2024.e24715.
Kwok S, Forward S, Fahlberg M, Assita E, Cosgriff S, Lee S
Nat Biomed Eng. 2023; 8(3):310-324.
PMID: 38036616
PMC: 10963263.
DOI: 10.1038/s41551-023-01144-9.
Schonbacher M, Banfi C, Berghold A, Matzhold E, Wagner T, Mayr W
Transfus Med Hemother. 2023; 50(4):294-302.
PMID: 37767286
PMC: 10521241.
DOI: 10.1159/000527233.
The Emerging Role of Raman Spectroscopy as an Omics Approach for Metabolic Profiling and Biomarker Detection toward Precision Medicine.
Cutshaw G, Uthaman S, Hassan N, Kothadiya S, Wen X, Bardhan R
Chem Rev. 2023; 123(13):8297-8346.
PMID: 37318957
PMC: 10626597.
DOI: 10.1021/acs.chemrev.2c00897.
Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy.
Gorovits B, Azadeh M, Buchlis G, Fiscella M, Harrison T, Havert M
AAPS J. 2023; 25(3):47.
PMID: 37101079
PMC: 10132926.
DOI: 10.1208/s12248-023-00814-5.
Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical Needs.
Cordone I, Amodeo R, Bellesi S, Bottan F, Buccisano F, De Propris M
Cancers (Basel). 2023; 15(7).
PMID: 37046720
PMC: 10093543.
DOI: 10.3390/cancers15072060.
Highly sensitive single tube B-lymphoblastic leukemia/lymphoma minimal/measurable residual disease test robust to surface antigen directed therapy.
Gao Q, Liu Y, Aypar U, Baik J, Londono D, Sun X
Cytometry B Clin Cytom. 2023; 104(4):279-293.
PMID: 36999235
PMC: 10508218.
DOI: 10.1002/cyto.b.22120.
Validation of an ICH Q2 Compliant Flow Cytometry-Based Assay for the Assessment of the Inhibitory Potential of Mesenchymal Stromal Cells on T Cell Proliferation.
Piede N, Bremm M, Farken A, Pfeffermann L, Cappel C, Bonig H
Cells. 2023; 12(6).
PMID: 36980191
PMC: 10047294.
DOI: 10.3390/cells12060850.
Standardization of flow cytometry and cell sorting to enable a transcriptomic analysis in a multi-site sarcoidosis study.
Magallon R, Harmacek L, Arger N, Grewal P, Powers L, Werner B
PLoS One. 2023; 18(3):e0281210.
PMID: 36893197
PMC: 9997938.
DOI: 10.1371/journal.pone.0281210.
Comparative diagnostic accuracy between simplified and original flow cytometric gating strategies for peripheral blood neutrophil myeloperoxidase expression in ruling out myelodysplastic syndromes.
Raskovalova T, Scheffen L, Jacob M, Vettier C, Bulabois B, Szymanski G
PLoS One. 2022; 17(11):e0276095.
PMID: 36399441
PMC: 9674135.
DOI: 10.1371/journal.pone.0276095.
Optimization of 3D-aggregated spheroid model (3D-ASM) for selecting high efficacy drugs.
Lee S, Hwang H, Lee D
Sci Rep. 2022; 12(1):18937.
PMID: 36344810
PMC: 9640609.
DOI: 10.1038/s41598-022-23474-5.
Flow cytometry lyophilised-reagent tube for quantifying peripheral blood neutrophil myeloperoxidase expression in myelodysplastic syndromes (MPO-MDS-Develop): protocol for a diagnostic accuracy study.
Raskovalova T, Scheffen L, Jacob M, Chevalier S, Tondeur S, Bulabois B
BMJ Open. 2022; 12(10):e065850.
PMID: 36207039
PMC: 9557768.
DOI: 10.1136/bmjopen-2022-065850.
Generic Multiplex Digital PCR for Accurate Quantification of T Cells in Copy Number Stable and Unstable DNA Samples.
Nell R, Zoutman W, Versluis M, van der Velden P
Methods Mol Biol. 2022; 2453:191-208.
PMID: 35622328
PMC: 9761916.
DOI: 10.1007/978-1-0716-2115-8_12.
Immunophenotyping: Analytical approaches and role in preclinical development of nanomedicines.
Newton H, Dobrovolskaia M
Adv Drug Deliv Rev. 2022; 185:114281.
PMID: 35405297
PMC: 9164149.
DOI: 10.1016/j.addr.2022.114281.
Clinical relevance of an objective flow cytometry approach based on limit of detection and limit of quantification for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial.
Buccisano F, Palmieri R, Piciocchi A, Arena V, Maurillo L, Del Principe M
Haematologica. 2022; 107(12):2823-2833.
PMID: 35295076
PMC: 9713557.
DOI: 10.3324/haematol.2021.279777.
Impact of Pre-Analytical and Analytical Variables Associated with Sample Preparation on Flow Cytometric Stainings Obtained with EuroFlow Panels.
Sedek L, Flores-Montero J, Van der Sluijs A, Kulis J, Te Marvelde J, Philippe J
Cancers (Basel). 2022; 14(3).
PMID: 35158741
PMC: 8833630.
DOI: 10.3390/cancers14030473.
Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party.
Tettero J, Freeman S, Buecklein V, Venditti A, Maurillo L, Kern W
Hemasphere. 2021; 6(1):e676.
PMID: 34964040
PMC: 8701786.
DOI: 10.1097/HS9.0000000000000676.
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Heuser M, Freeman S, Ossenkoppele G, Buccisano F, Hourigan C, Ngai L
Blood. 2021; 138(26):2753-2767.
PMID: 34724563
PMC: 8718623.
DOI: 10.1182/blood.2021013626.